临床耳鼻咽喉头颈外科杂志2024,Vol.38Issue(7) :661-665.DOI:10.13201/j.issn.2096-7993.2024.07.020

糖皮质激素抵抗在耳鼻咽喉疾病中的研究进展

Advances in glucocorticoid resistance in otorhinolaryngological diseases

李亚秀 佘万东
临床耳鼻咽喉头颈外科杂志2024,Vol.38Issue(7) :661-665.DOI:10.13201/j.issn.2096-7993.2024.07.020

糖皮质激素抵抗在耳鼻咽喉疾病中的研究进展

Advances in glucocorticoid resistance in otorhinolaryngological diseases

李亚秀 1佘万东1
扫码查看

作者信息

  • 1. 南京医科大学鼓楼临床医学院耳鼻咽喉头颈外科(南京,210008)
  • 折叠

摘要

糖皮质激素(glucocorticoids,GC)临床上广泛应用于自身免疫性内耳病、突发性聋、梅尼埃病及鼻窦炎等耳鼻咽喉疾病的治疗,部分患者存在GC抵抗现象,但导致GC抵抗因素机制尚不清楚,本文从GC受体因素和非GC受体因素两方面阐述了 GC抵抗的相关机制,并综述其在耳鼻咽喉科疾病的最新研究进展,旨在未来寻找GC抵抗生物标志物,提高GC疗效提出新策略.

Abstract

Glucocorticoids(GC)are widely used in the clinical treatment of autoimmune inner ear diseases,sudden sensorineural hearing loss,Meniere's disease,sinusitis and other otolaryngology diseases.However,GC resistance remains a major factor contributing to the poor efficacy of clinical treatments.The mechanism of GC re-sistance is still unclear.This paper reviews the related mechanisms of GC resistance from the perspectives of GC receptor factors and non-GC receptor factors.Additionally,it summarizes the latest research progress on GC re-sistance in otolaryngological diseases,with the aim of identifying effective clinical alternative treatment options for reversing GC resistance in the future.

关键词

糖皮质激素抵抗/糖皮质激素/糖皮质激素受体/突发性聋/鼻窦炎

Key words

glucocorticoid resistance/glucocorticoids/receptor/sudden sensorineural hearing loss/sinusitis

引用本文复制引用

基金项目

国家自然科学基金(81670931)

南京市医学重点科技发展项目(ZKX-21012)

江苏省自然科学基金(BK20231122)

南京鼓楼医院临床研究专项资金面上项目(2022-LCYJ-NMS-01)

出版年

2024
临床耳鼻咽喉头颈外科杂志
华中科技大学同济医学院附属协和医院

临床耳鼻咽喉头颈外科杂志

CSTPCD北大核心
影响因子:0.831
ISSN:1001-1781
参考文献量2
段落导航相关论文